Health
With demand uncertain and its U.S. manufacturing in limbo, AstraZeneca still aims to seek FDA nod for COVID-19 vaccine – FiercePharma
AstraZeneca’s target window to apply for emergency use authorization of its troubled COVID-19 vaccine in the U.S. has passed. But the company still plans to seek…
Its COVID-19 vaccine has been vilified and its manufacturing network has been questioned, but AstraZeneca is still planning to apply for emergency use authorization of its shot in the U.S., a company spokesman confirmed.
A month ago, after AZ said its vaccine succeeded in phase 3 testing, an AstraZeneca executive said the company would apply for an emergency nod in America in the first half of April.
Assuming that the approval will take place in a fast way, we hope to deliver 30 million doses instantly,…
-
General19 hours agoWe’ve all talked about potential economic consequences for Australia of Trump’s policies. Now they’re happening
-
Business17 hours ago$10,000 invested in ANZ shares 5 years ago is now worth…
-
Noosa News19 hours agoRates on hold; pressure builds for cuts in May
-
General16 hours agoStephanie Scott’s murder caused a ‘seismic’ shock in Leeton, and the hurt remains